Skip to content
Search

Latest Stories

BMI linked to work absenteeism, NHS expands obesity and type 2 diabetes programme

BMI linked to work absenteeism, NHS expands obesity and type 2 diabetes programme
Wider rollout of NHS soup and shake diet to help 10,000+ with type 2 diabetes and obesity

A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic productivity.

The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick leave.


According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight.

The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and heart disease.

In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.

The study indicates that soaring obesity levels contribute significantly to the country's record sickness levels, with approximately 2.8 million people currently signed off work due to health issues.

It underscores the urgency of implementing anti-obesity measures to promote economic growth and reduce the economic impact of obesity-related health conditions.

Furthermore, the rising sick note culture in the UK, characterised by a doubling in the number of sick notes issued by the NHS over the past decade, poses a significant economic burden, as per the The Sunday Times. 

The estimated cost of rising sick leave is a staggering £33 billion annually in lost productivity.

In response to these findings, prime minister Rishi Sunak has announced reforms aimed at addressing the "sick-note culture," emphasising the need to tackle obesity as a root cause of health problems driving individuals out of the workforce.

NHS 'Soup and Shake Diets' to tackle obesity epidemic in 42 local health areas 

The NHS's rollout of "soup and shake" diets as part of efforts to tackle obesity and reverse type 2 diabetes represents a significant step towards addressing the obesity epidemic.

Under the new expansion plan, the NHS Type 2 Diabetes Path to Remission Programme will double its capacity, benefiting over 10,000 individuals struggling with type 2 diabetes and excess weight or obesity.

This national rollout will cover 42 local health areas, ensuring accessibility for eligible patients across the country.

Patients referred by the GPs will be given diet replacement products like milkshakes and soups with 800 to 900 calories per day upto 3 months along with support from diet coaches and clinicians to tackle obesity and related conditions.

According to The Telegraph, more than 50,000 people are set to sign up for the obesity programme in the coming 5 years costing an average of £1,000 per head for the weight loss plan.

Health chiefs are investing £13 million this year to support the programme’s expansion, and since the peak of the Covid-19 pandemic, local NHS teams have been given £36 million by NHS England to help restore their diabetes services to pre-pandemic levels.

Amanda Pritchard, NHS chief executive, emphasised the life-changing potential of the programme, stating that the new rollout "can be truly life-changing in helping reverse the effects of the condition."

Emphasising on holistic approach to tackling obesity and type 2 diabetes, the NHS National Clinical Director for Diabetes and Obesity, Dr Clare Hambling said:

“Our NHS Type 2 Diabetes Path to Remission Programme, sits alongside the success of our world-leading Healthier You NHS Diabetes Prevention Programme – which independent evaluation has shown to successfully reduce the risk of developing type 2 diabetes by more than a third for people who complete the programme.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less